Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Core EBITDA Growth

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 14.6689.44-31.9410.9452.63

What is the latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA ?

The latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA is 14.66 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202414.66
Mar202389.44
Mar2022-31.94
Mar202110.94
Mar202052.63

How is Core EBITDA Growth of ASTRAZENECA PHARMA INDIA Trending?

Years Core EBITDA Growth % Change
Mar2024 14.66
-83.61
Mar2023 89.44
Positive
Mar2022 -31.94
Negative
Mar2021 10.94
-79.21
Mar2020 52.63 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare Core EBITDA Growth ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹17,284.9 Cr -1.8% 6.7% 9.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,557.0 Cr 2.3% -0.8% 32.7% Stock Analytics
DIVIS LABORATORIES ₹156,994.0 Cr 3.2% 1.1% 51.5% Stock Analytics
CIPLA ₹116,494.0 Cr 0.3% -2% 10% Stock Analytics
DR REDDYS LABORATORIES ₹109,297.0 Cr -1.8% 2.7% 12.7% Stock Analytics
ZYDUS LIFESCIENCES ₹100,035.0 Cr 2% 1.5% 38% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

-1.8%

6.7%

9.7%

SENSEX

-1%

-5%

5.6%


You may also like the below Video Courses